Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer.
<h4>Introduction</h4>Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonl...
Guardado en:
Autores principales: | Alexander Link, Verena Becker, Ajay Goel, Thomas Wex, Peter Malfertheiner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f1b5d5613ec42fd927b81931aed673d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum microRNAs are promising novel biomarkers.
por: Shlomit Gilad, et al.
Publicado: (2008) -
MicroRNAs as B-cell lymphoma biomarkers
por: Manterola L, et al.
Publicado: (2015) -
LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
Circulating microRNAs as specific biomarkers for breast cancer detection.
por: Enders K O Ng, et al.
Publicado: (2013) -
MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
por: Rytkin E, et al.
Publicado: (2021)